研究领域（方向）：

过敏性疾病诊断标志物的发现及体外诊断试剂研发

靶向性抗过敏药物筛选及评价

过敏性疾病机制和治疗药物评价研究

个人及工作简历

个人受教育及工作经历

(1) 2021-11至今,西安交通大学,药学院,助理教授

(2) 2017-09至2021-09,西安交通大学,药物分析学,博士

(3) 2014-09至2017-07,西安交通大学,药物分析学,硕士

(4) 2009-09至2013-07,西安交通大学,药学,学士

科研项目：

（1）国家自然科学基金青年项目1项（2023-2025）

（2）中国博士后科学基金面上项目1项（2024-2025）

学术及科研成果、专利、论文

以第一或通讯作者发表SCI论文10余篇，申请专利8项，授权6项。

近年发表部分SCI论文如下：

(1) Yuanyuan Ding; Yuejin Wang; Yonghui Zhang; Baowen Dang; Shiting Hu; Chenrui Zhao; Yihan Huang; Guodong Zheng; Tianyou Ma; Tao Zhang; Alpha-linolenic acid improves nasal mucosa epithelial barrier function in allergic rhinitis by arresting CD4⁺T cell differentiation via IL-4Rα-JAK2-STAT3 pathway, Phytomedicine, 2023, 116: 154825.

(2) Yuanyuan Ding; Tianyou Ma; Yonghui Zhang; Chenrui Zhao; Chao Wang; Zhao Wang; Rosmarinic acid ameliorates skin inflammation and pruritus in allergic contact dermatitis by inhibiting mast cell-mediated MRGPRX2/PLCγ1signaling pathway, International Immunopharmacology, 2023, 117:110003.

(3) Yuanyuan Ding; Baowen Dang; Yonghui Zhang; Shiting Hu; Yuejin Wang; Chenrui Zhao; Tao Zhang; Zijun Gao; Paeonol attenuates Substance P-induced urticaria by inhibiting Src kinase phosphorylation in mast cells, Cellular Immunology, 2023, 388-389: 104728.

(4) Yuanyuan Ding; Baowen Dang; Yuejin Wang; Chenrui Zhao; Hongli An; Artemisinic acid attenuated symptoms of substance P-induced chronic urticaria in a mice model and mast cell degranulation via Lyn/PLC-p38 signal pathway, International Immunopharmacology, 2022, 113:109437.

(5) Yuanyuan Ding; Yuejin Wang; Chaomei Li; Yongjing Zhang; Shiling Hu; Jiapan Gao; Rui Liu; Hongli An;α-Linolenic acid attenuates pseudo-allergic reactions by inhibiting Lyn kinase activity, Phytomedicine, 2021, 80: 153391.

(6)Yuanyuan Ding; Tao Zhang; Rui Liu; Delu Che; Nan Wang; Langchong He ; A novel ELISAmethod to determine human MrgX2 in chronic urticaria, Clinical and Translational Allergy, 2020,10(1): 61.